yvandenbroek
/
sprookjes
/
Login
Register
TriplyDB
sprookjes
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
2
CNCR.22097
CNCR.22097
http://dx.doi.org/10.1002/CNCR.22097
Phase II study of single-agent bortezomib for the treatment of patients with fludarabine-refractory B-cell chronic lymphocytic leukemia.
P356
Q33371900-221D976B-D745-4802-AB38-D9FDAFA65C8C
P356
CNCR.22097
http://dx.doi.org/10.1002/CNCR.22097